APA (7th ed.) Citation

Prasad, M., Ponnalagu, S., Zeng, Q., Luu, K., Lang, S. M., Wong, H. Y., . . . Schwarz, H. (2022). Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors. Cancer Immunology Immunotherapy, 71(11), 2583-2596. https://doi.org/10.1007/s00262-022-03183-8

Chicago Style (17th ed.) Citation

Prasad, Mukul, et al. "Epstein-Barr Virus-induced Ectopic CD137 Expression Helps Nasopharyngeal Carcinoma to Escape Immune Surveillance and Enables Targeting by Chimeric Antigen Receptors." Cancer Immunology Immunotherapy 71, no. 11 (2022): 2583-2596. https://doi.org/10.1007/s00262-022-03183-8.

MLA (9th ed.) Citation

Prasad, Mukul, et al. "Epstein-Barr Virus-induced Ectopic CD137 Expression Helps Nasopharyngeal Carcinoma to Escape Immune Surveillance and Enables Targeting by Chimeric Antigen Receptors." Cancer Immunology Immunotherapy, vol. 71, no. 11, 2022, pp. 2583-2596, https://doi.org/10.1007/s00262-022-03183-8.